The UK Medicines and Healthcare products Regulatory Agency will develop an AI protocol checker to help clinical trial sponsors.
Europe's clinical trial numbers have fallen 13.5% annually since 2013, with late-stage and non-commercial trials declining.
METiS TechBio has teamed up with Lilly in a deal worth $1.1bn, pairing AI-driven lipid design with pharma expertise to ...
Pharma executive Tim Tallent explains why drugmakers want more transparency in the 340B program amid rising contract pharmacy ...
IQVIA and Veeva extend their partnership, expanding sponsor access to Veeva's clinical trial and data management technology.
BioXconomy highlights leading Black innovators and leaders in the biotechnology industry.
Germany’s Merck has agreed to acquire London-based Silence Therapeutics in an all-cash deal, adding a late-stage rare blood ...
Labcorp acquires BioReference Health assets from OPKO for $722 million, expanding reach of its FDA-approved 4Kscore prostate ...
Dan is currently a trade media relations expert at Sartorius, a life science research and biopharmaceutical technology provider. He formerly led the news domain of Bioprocess International. He has ...
Estuary Biotherapeutics launches with $103 million to take gene therapies for kidney disease into the clinic. The financing ...
Biopharma finance leaders detail how they build and refine gross-to-net models amid shrinking margins across biopharma ...
The clinical-stage biotech has closed an oversubscribed Series D financing round in a bid to meeting its mission to stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results